MedPath

The comparison of vancomycin and teicoplanin in treatment of hospitalized children with severe pneumonia

Phase 3
Conditions
Pneumonia.
Pneumonia, unspecified
Registration Number
IRCT2015030111145N13
Lead Sponsor
Kashan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
100
Inclusion Criteria

children 2 months to 12 years old hospitalized in Pediatrics Intensive Care Unit of Kashan Beheshti Hospital; fever (axillary temperature 37.5° C or more); tachypnea; respiratory distress. Exclusion criteria: the history of pulmonary disease including asthma; documented heart disease or other chronic disease; renal disease; immunodeficiency; malnutrition or growth failure.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fever improvement. Timepoint: Every 6 hours. Method of measurement: Mercury thermometer with axillary method.;Tachypnea improvement. Timepoint: Daily. Method of measurement: Breathing rate.;Improvment of respiratory distress. Timepoint: Daily. Method of measurement: Observed breathing.
Secondary Outcome Measures
NameTimeMethod
Renal failure. Timepoint: Daily. Method of measurement: creatinin measurement (milligram/deciliter).;Red man syndrome. Timepoint: During injection. Method of measurement: Observed by nurse.;Duration of hospital stay. Timepoint: At discharge. Method of measurement: Days recorded in dossier.
© Copyright 2025. All Rights Reserved by MedPath